The most frequently reported side effects during retatrutide initiation are gastrointestinal, including nausea, vomiting, diarrhoea, and abdominal discomfort
Patients with liver disease should follow guidance from the American Association for the Study of Liver Diseases: those with cirrhosis or advanced liver disease should abstain from alcohol completely, while those with milder forms of liver disease, including hepatic steatosis (fatty liver) or early hepatitis, should discuss safe limits with their healthcare provider
This category includes alogliptin, linagliptin, sitagliptin, and saxagliptin
A stacked strategy focused on training intensity, nutrition consistency, and supplementation can enhance overall results
Gerstenberg et al
Tirzepatide might make people less likely to feel thirsty while on it